Systematic review / meta-analysis / 2020
Vitamin K supplementation does not consistently prevent the progression of arterial calcification, atherosclerosis, or arterial stiffness.
A systematic review evaluated 9 randomized controlled trials examining vitamin K1 or vitamin K2 supplementation on surrogate markers of cardiovascular disease in adults. The findings indicated that vitamin K does not consistently prevent the progression of calcification, atherosclerosis, or arterial stiffness, though there may be some benefit in individuals with calcification at study entry. Although supplementation improves the carboxylation of dephosphorylated matrix gla protein, its role in mitigating vascular calcification remains uncertain. The authors noted that studies were heterogeneous, had relatively short follow-up periods, and used varied outcome measures.
- Study type
- Systematic review of randomized controlled trials
- Who was studied
- Adults across 9 randomized controlled trials
- What was measured
- Surrogate measures of cardiovascular disease including artery/valve calcification, atherosclerosis, and artery stiffening
THE PAPER
Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
Vlasschaert C, Goss CJ, Pilkey NG, McKeown S, Holden RM. Nutrients, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.